Saturation Editing of RNU4-2 Reveals Distinct Dominant and Recessive Disorders

Why It Matters

By delivering functional evidence for every possible RNU4‑2 mutation, the study enables precise diagnostic classification and informs prognosis for both dominant and recessive neurodevelopmental disorders, addressing a major gap in non‑coding variant interpretation.

Key Takeaways

• Saturation genome editing mapped functional impact of 539 RNU4-2 variants.
• Assay distinguished all known ReNU syndrome variants from population controls (AUC 0.93).
• Redefined critical region to two sub‑segments (9 nt and 4 nt) with 85% depletion.
• Depleted variants outside critical region cause recessive NDD in 20 patients.
• Function scores predict severity: strong depletion links to severe developmental delay.

Pulse Analysis

The spliceosome’s intricate choreography depends on small nuclear RNAs, yet the clinical relevance of mutations in these non‑coding components has remained opaque. RNU4‑2, which encodes the U4 snRNA of the major spliceosome, was linked to ReNU syndrome—a prevalent neurodevelopmental disorder affecting an estimated 100,000 people worldwide. Traditional genetic screens struggle to assess the functional impact of every possible nucleotide change in such highly conserved RNAs, creating uncertainty for clinicians interpreting rare variants.

To overcome this barrier, the authors deployed saturation genome editing in haploid HAP1 cells, constructing a library of 539 single‑base substitutions, insertions, and deletions across the entire RNU4‑2 transcript. By measuring variant‑driven changes in cell fitness, they generated quantitative function scores that distinguished pathogenic ReNU‑associated mutations from benign polymorphisms with an impressive AUC of 0.93, far surpassing in silico predictors like CADD. The data sharpened the previously defined 18‑nt critical region into two tighter hotspots—nine nucleotides in the T‑loop and four in Stem III—where 85 % of tested variants are deleterious, and also revealed a spectrum of functional effects that correlate with clinical severity.

Beyond the dominant disorder, the study uncovered a second, recessive neurodevelopmental phenotype linked to depleted variants outside the critical region. Twenty individuals harboring biallelic loss‑of‑function alleles presented with a distinct constellation of developmental delays, microcephaly, and white‑matter abnormalities, expanding the phenotypic landscape of RNU4‑2‑related disease. This dual‑mode insight illustrates how exhaustive functional atlases can guide precise genetic counseling, prioritize variants for diagnostic pipelines, and serve as a template for interrogating other disease‑relevant non‑coding RNAs. As genome sequencing becomes routine, such high‑resolution functional maps will be essential for translating raw variant calls into actionable medical knowledge.